Financhill
Sell
37

SU Quote, Financials, Valuation and Earnings

Last price:
$34.51
Seasonality move :
5.73%
Day range:
$34.27 - $34.97
52-week range:
$31.03 - $41.95
Dividend yield:
4.67%
P/E ratio:
7.53x
P/S ratio:
1.10x
P/B ratio:
1.30x
Volume:
3.6M
Avg. volume:
5M
1-year change:
8.63%
Market cap:
$43.4B
Revenue:
$38.7B
EPS (TTM):
$4.58
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $28.9B $18.4B $31.2B $48.4B $38.7B
Revenue Growth (YoY) -2.86% -36.29% 69.57% 54.91% -20.04%
 
Cost of Revenues $18.1B $14.6B $17.2B $27.7B $22.4B
Gross Profit $10.8B $3.8B $14B $20.7B $16.2B
Gross Profit Margin 37.4% 20.57% 44.87% 42.72% 42%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $3.7B $2.7B $7.5B $8B $7.9B
Other Inc / (Exp) $1.1B $470.2M $137.2M -$654.9M $1.7B
Operating Expenses $9.3B $8.1B $9B $10B $9.6B
Operating Income $1.5B -$4.3B $5B $10.7B $6.6B
 
Net Interest Expenses $678.1M $703.1M $715.5M $581.8M $512.5M
EBT. Incl. Unusual Items $1.9B -$4.6B $4.4B $9.5B $7.8B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$275.8M -$1.3B $1.2B $2.5B $1.7B
Net Income to Company $2.2B -$3.2B $3.3B $7B $6.1B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $2.2B -$3.2B $3.3B $7B $6.1B
 
Basic EPS (Cont. Ops) $1.40 -$2.11 $2.21 $5.03 $4.70
Diluted EPS (Cont. Ops) $1.40 -$2.11 $2.21 $5.02 $4.69
Weighted Average Basic Share $1.6B $1.5B $1.5B $1.4B $1.3B
Weighted Average Diluted Share $1.6B $1.5B $1.5B $1.4B $1.3B
 
EBITDA $10.6B $3.3B $9.9B $16.9B $13.2B
EBIT $2.7B -$3.8B $5.2B $10.2B $8.4B
 
Revenue (Reported) $28.9B $18.4B $31.2B $48.4B $38.7B
Operating Income (Reported) $1.5B -$4.3B $5B $10.7B $6.6B
Operating Income (Adjusted) $2.7B -$3.8B $5.2B $10.2B $8.4B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $4.8B $8.1B $12.2B $10.4B $10.2B
Revenue Growth (YoY) -35.01% 67.02% 50.88% -14.71% -1.7%
 
Cost of Revenues $3.1B $4.1B $9.1B $5.7B $5.6B
Gross Profit $1.8B $4B $3.1B $4.6B $4.6B
Gross Profit Margin 36.3% 49.64% 25.23% 44.6% 45.29%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $240.9M $355.7M $357.6M $307M $354.7M
Other Inc / (Exp) $228.9M -$212M -$481.7M -$198.2M $93.1M
Operating Expenses $2B $2.6B $2.8B $2.7B $2.7B
Operating Income -$229.6M $1.4B $286.4M $1.9B $1.9B
 
Net Interest Expenses $177.1M $184.2M $171.5M $93.9M $24.9M
EBT. Incl. Unusual Items -$177.8M $1B -$366.8M $1.6B $2B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$168.8M $347M $99.6M $439.6M $493.9M
Net Income to Company -$129M $662M -$582.5M $1.2B $1.5B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$9M $696.3M -$466.4M $1.2B $1.5B
 
Basic EPS (Cont. Ops) -$0.01 $0.47 -$0.34 $0.89 $1.17
Diluted EPS (Cont. Ops) -$0.01 $0.47 -$0.34 $0.89 $1.17
Weighted Average Basic Share $1.5B $1.5B $1.4B $1.3B $1.3B
Weighted Average Diluted Share $1.5B $1.5B $1.4B $1.3B $1.3B
 
EBITDA $1.3B $2.2B $3.5B $3B $3.4B
EBIT $21M $1.2B -$189.2M $1.7B $2.1B
 
Revenue (Reported) $4.8B $8.1B $12.2B $10.4B $10.2B
Operating Income (Reported) -$229.6M $1.4B $286.4M $1.9B $1.9B
Operating Income (Adjusted) $21M $1.2B -$189.2M $1.7B $2.1B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $20.6B $27.4B $46.4B $39.5B $40.3B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $18.4B $15.2B $27.2B $21.6B $23.8B
Gross Profit $2.2B $12.3B $19.2B $17.9B $16.4B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- $3.3B $7.1B $7.7B $7.9B
Other Inc / (Exp) $376.6M $338.2M -$399.9M $770.4M $1.1B
Operating Expenses $8.4B $9.4B $9.6B $10.3B $9.4B
Operating Income -$6.3B $2.9B $9.6B $7.6B $7B
 
Net Interest Expenses $632.1M $729.8M $658.7M $467.4M $394.9M
EBT. Incl. Unusual Items -$6.5B $2.5B $8.5B $7.9B $7.7B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$1.7B $547.8M $2.3B $1.9B $1.8B
Net Income to Company -$4.9B $1.9B $6.1B $6.2B $5.9B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$4.8B $1.9B $6.2B $6.1B $5.9B
 
Basic EPS (Cont. Ops) -$3.17 $1.28 $4.35 $4.59 $4.58
Diluted EPS (Cont. Ops) -$3.17 $1.28 $4.34 $4.58 $4.58
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $4.4B $8.3B $16.2B $13.2B $13.2B
EBIT -$5.8B $3.3B $9.3B $8.5B $8.2B
 
Revenue (Reported) $20.6B $27.4B $46.4B $39.5B $40.3B
Operating Income (Reported) -$6.3B $2.9B $9.6B $7.6B $7B
Operating Income (Adjusted) -$5.8B $3.3B $9.3B $8.5B $8.2B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $13.4B $22.4B $37.5B $28.7B $30.3B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $10.7B $11.1B $21.1B $15.1B $16.5B
Gross Profit $2.7B $11.2B $16.4B $13.6B $13.8B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $771.4M $1.3B $955.6M $923.8M $978.7M
Other Inc / (Exp) $54.7M -$78.4M -$615.7M $771.2M $118.9M
Operating Expenses $6.5B $7.8B $8.4B $8.7B $8.5B
Operating Income -$3.7B $3.4B $8B $4.9B $5.3B
 
Net Interest Expenses $516.9M $544.1M $487.4M $334.1M $217.1M
EBT. Incl. Unusual Items -$4.2B $2.8B $6.9B $5.3B $5.2B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$1.1B $757.3M $1.9B $1.3B $1.4B
Net Income to Company -$3.1B $2B $4.9B $4.1B $3.8B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$3.1B $2.1B $5B $4.1B $3.8B
 
Basic EPS (Cont. Ops) -$2.02 $1.37 $3.50 $3.10 $2.98
Diluted EPS (Cont. Ops) -$2.02 $1.37 $3.50 $3.09 $2.98
Weighted Average Basic Share $4.6B $4.5B $4.2B $3.9B $3.8B
Weighted Average Diluted Share $4.6B $4.5B $4.2B $3.9B $3.8B
 
EBITDA $1.9B $6.8B $13.1B $9.4B $9.3B
EBIT -$3.6B $3.4B $7.4B $5.8B $5.6B
 
Revenue (Reported) $13.4B $22.4B $37.5B $28.7B $30.3B
Operating Income (Reported) -$3.7B $3.4B $8B $4.9B $5.3B
Operating Income (Adjusted) -$3.6B $3.4B $7.4B $5.8B $5.6B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $1.5B $1.5B $1.7B $1.5B $1.3B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $3.1B $2.5B $3.6B $4.5B $4.3B
Inventory $2.9B $2.8B $3.2B $3.7B $4B
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets $7.6B $7.4B $8.6B $10.7B $10.4B
 
Property Plant And Equipment $57.5B $55.2B $53.2B $47.6B $52.3B
Long-Term Investments $221.2M $253.3M $306.7M $225.5M $369.4M
Goodwill $2.2B $2.3B $2.3B $2.1B $2.2B
Other Intangibles $127.1M $341.9M $494.9M $511.3M $479.4M
Other Long-Term Assets $692.8M $748.1M $718.4M $565.1M $265.3M
Total Assets $68.5B $66.4B $65.7B $62.3B $66.7B
 
Accounts Payable $5B $3.7B $5.1B $6B $5.8B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- $1.1B $181.2M -- --
Current Portion Of Capital Lease Obligations $237.3M $213.3M $243.1M $233.6M $262.3M
Other Current Liabilities -- -- -- $390.5M --
Total Current Liabilities $8.1B $8.3B $8.2B $9.5B $7.2B
 
Long-Term Debt $9.9B $10.8B $11B $7.2B $8.4B
Capital Leases -- -- -- -- --
Total Liabilities $36.3B $38.3B $37B $33.3B $34.1B
 
Common Stock $19.3B $19.7B $18.5B $16.4B $16.3B
Other Common Equity Adj $688.2M $687.8M $638.4M $717.7M $790M
Common Equity $32.2B $28B $28.7B $29B $32.6B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $32.2B $28B $28.7B $29B $32.6B
 
Total Liabilities and Equity $68.5B $66.4B $65.7B $62.3B $66.7B
Cash and Short Terms $1.5B $1.5B $1.7B $1.5B $1.3B
Total Debt $11.5B $14.7B $12.2B $9.3B $8.7B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $1.1B $1.8B $3.4B $1.8B $2.2B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $2B $3.3B $5.6B $5.4B $4.5B
Inventory $2.5B $3.2B $3.8B $3.8B $3.9B
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets $6.2B $8.6B $13.7B $11.3B $11.1B
 
Property Plant And Equipment $52.6B $53.5B $44.7B $47.4B $52B
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $949.5M $1B $1.1B $1.5B $1.3B
Total Assets $62.4B $66B $62.2B $62.8B $67.1B
 
Accounts Payable $3.5B $5.4B $6.8B $6.3B $5.9B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt $2.2B $1.6B $2.1B $1.8B --
Current Portion Of Capital Lease Obligations $204M $246.2M $223M $236.2M $339M
Other Current Liabilities -- $141.9M $556.5M -- --
Total Current Liabilities $6.4B $8.7B $10.9B $9.1B $7B
 
Long-Term Debt $11.5B $11B $9.9B $7.2B $8.1B
Capital Leases -- -- -- -- --
Total Liabilities $35.2B $37.5B $34.2B $32.1B $33.7B
 
Common Stock -- $18.8B $16.5B $16B $15.8B
Other Common Equity Adj -- $660.1M $753.2M $832.8M $733.5M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $27.2B $28.5B $27.9B $30.7B $33.4B
 
Total Liabilities and Equity $62.4B $66B $62.2B $62.8B $67.1B
Cash and Short Terms $1.1B $1.8B $3.4B $1.8B $2.2B
Total Debt $13.7B $12.6B $11.9B $9B $8.1B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $2.2B -$3.2B $3.3B $7B $6.1B
Depreciation & Amoritzation $8B $7.1B $4.7B $6.8B $4.8B
Stock-Based Compensation $33.2M -$177.6M $163.5M $252.1M $80M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $7.9B $2B $9.4B $12.1B $9.1B
 
Capital Expenditures $4.2B $2.9B $3.6B $3.9B $4.4B
Cash Acquisitions -- -- -- -- -$1.8B
Cash From Investing -$3.8B -$3.4B -$3.2B -$3.7B -$4.8B
 
Dividends Paid (Ex Special Dividend) -$2B -$1.2B -$1.2B -$2B -$2B
Special Dividend Paid
Long-Term Debt Issued -- $2B $1.1B -- $1.1B
Long-Term Debt Repaid -$231.3M -$250M -$2.2B -$4.2B -$248.8M
Repurchase of Common Stock -$1.7B -$229.1M -$1.8B -$3.9B -$1.7B
Other Financing Activities -$5.3M -$7.5M -$7.2M -$6.9M -$11.8M
Cash From Financing -$4.2B $1.3B -$6B -$8.6B -$4.4B
 
Beginning Cash (CF) $1.7B $1.5B $1.5B $1.7B $1.5B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$153.7M -$47M $257.6M -$259M -$116.3M
Ending Cash (CF) $1.5B $1.4B $1.8B $1.5B $1.3B
 
Levered Free Cash Flow $3.7B -$933.7M $5.8B $8.1B $4.7B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$129M $662M -$582.5M $1.2B $1.5B
Depreciation & Amoritzation $1.5B $906.1M $3.7B $1.3B $1.3B
Stock-Based Compensation -$41.4M -$809.6K -$25.4M $166.6M $47M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $952M $3.7B $3.3B $3.1B $3.1B
 
Capital Expenditures $764.6M $925.8M $1B $1.2B $1.1B
Cash Acquisitions -- -- -- $529.3M --
Cash From Investing -$683.6M -$903.3M -$717.4M -$1.2B -$1.2B
 
Dividends Paid (Ex Special Dividend) -$270.7M -$232.5M -$467.6M -$506.1M -$508.6M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $76.3M -$28.9M -$210.5M -- --
Long-Term Debt Repaid -$67.2M -$847.8M -$32M -$325.9M -$694.4M
Repurchase of Common Stock -$8.9M -$539.4M -$732.3M -$226.3M -$581.3M
Other Financing Activities -$2.4M -$1.5M -$2.2M -$3M -$2.9M
Cash From Financing -$528.7M -$2.5B -$343.2M -$2B -$1.4B
 
Beginning Cash (CF) $1.3B $1.7B $1.3B $1.9B $1.7B
Foreign Exchange Rate Adjustment -$10.9M $10.6M $73.6M $8.1M -$23.4M
Additions / Reductions -$260.2M $203.9M $2.2B -$139.6M $487.1M
Ending Cash (CF) $1.1B $1.8B $3.6B $1.8B $2.2B
 
Levered Free Cash Flow $187.5M $2.7B $2.2B $1.9B $2B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$4.9B $1.9B $6.1B $6.2B $5.9B
Depreciation & Amoritzation $10.1B $4.9B $6.9B $4.8B $4.9B
Stock-Based Compensation -$202.3M $135.8M $223.3M $158.6M -$104.4M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $3.1B $7.9B $11.1B $9B $11.1B
 
Capital Expenditures $3.5B $3.4B $3.9B $4.3B $4.7B
Cash Acquisitions -- -- -- -- -$1.8B
Cash From Investing -$3.9B -$3.3B -$3.1B -$3.6B -$6B
 
Dividends Paid (Ex Special Dividend) -$1.5B -$982.1M -$1.9B -$2.1B -$2B
Special Dividend Paid
Long-Term Debt Issued -- $1.1B -- -- --
Long-Term Debt Repaid -$247.8M -$1.9B -$1.7B -$3.3B -$641.5M
Repurchase of Common Stock -$564.5M -$1.3B -$3.9B -$2B -$1.7B
Other Financing Activities -$6.7M -$7M -$7M -$10.5M -$11.7M
Cash From Financing $390.6M -$3.9B -$6.3B -$7.1B -$4.7B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$451.7M $659.6M $1.7B -$1.7B $434.4M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$440.5M $4.5B $7.3B $4.7B $6.4B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$3.1B $2B $4.9B $4.1B $3.8B
Depreciation & Amoritzation $5.6B $3.4B $5.6B $3.6B $3.7B
Stock-Based Compensation -$249.9M $63.5M $123.3M $29.8M -$154.6M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $1.4B $7.3B $9B $6B $8B
 
Capital Expenditures $2.2B $2.7B $2.9B $3.3B $3.6B
Cash Acquisitions -- -- -- -$10 --
Cash From Investing -$2.6B -$2.5B -$2.5B -$2.4B -$3.5B
 
Dividends Paid (Ex Special Dividend) -$1B -$748.7M -$1.5B -$1.5B -$1.5B
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $2B $1.1B -- -- --
Long-Term Debt Repaid -$190.6M -$1.8B -$1.4B -$451.6M -$844.2M
Repurchase of Common Stock -$230.4M -$1.3B -$3.4B -$1.4B -$1.4B
Other Financing Activities -$6M -$5.6M -$5.4M -$8.9M -$8.8M
Cash From Financing $823.9M -$4.4B -$4.7B -$3.3B -$3.5B
 
Beginning Cash (CF) $4.5B $4.5B $5.1B $4.2B $4.8B
Foreign Exchange Rate Adjustment $15.8M -$794K $104.9M -$39.5M $8.1M
Additions / Reductions -$369.2M $337.4M $1.8B $376.3M $927M
Ending Cash (CF) $4.1B $4.9B $6.9B $4.6B $5.8B
 
Levered Free Cash Flow -$823.9M $4.6B $6.1B $2.7B $4.4B

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 6.11% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 16.63% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 1.74% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock